Our Policies
News

Newsletter

16 de October de 2017

The Brazilian Patent and Trademark Office (BPTO) launches a PPH Pilot Program with the European Patent Office (EPO)

This time, the measure consists of a cooperation agreement signed between the BPTO and the EPO by means of a PPH (Patent Prosecution Highway) Pilot Program exclusively directed to inventions in the Medical Technology and the Chemistry areas (excluding pharmaceutical products).
 
The new program will accept a maximum of 300 applications per year, whose examinations will be accelerated after the grant of the corresponding patents by the EPO.
 
Nowadays, Brazil already maintains PPH agreements with USA (Oil & Gas), Japan (information technology and mechanical engineering) and Latin-America countries that are members of Prosur.
 
Should you wish to receive more information on this subject, please do not hesitate to contact us, by e-mail or telephone, directly with your usual contact at our office or by e-mail at mail@kasznarleonardos.com
Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although … Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
    • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action … Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
    • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional … ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
    • Ler notícia

    Check out our Social Responsability and Sustainability projects

    Meet our complete team